USFDA classifies Cohance Lifesciences Telangana plant as VAI
In short
Cohance Lifesciences said the USFDA finished inspecting its Shamshabad facility in Telangana and classified it as Voluntary Action Indicated. The agency also issued an Establishment Inspection Report.
What the reporting says
Cohance Lifesciences said the USFDA completed an inspection of its Shamshabad facility in Telangana and classified it as Voluntary Action Indicated, issuing an Establishment Inspection Report. The classification can matter for the company’s regulatory standing and investor sentiment.
Why it matters
Cohance Lifesciences announced that the USFDA completed an inspection at its Shamshabad facility in Telangana and classified the site as Voluntary Action Indicated, while also issuing an Establishment Inspection Report. The update is relevant for Cohance because FDA inspection outcomes can affect how investors assess compliance and regulatory risk.